Design Therapeutics DSGN
NASDAQ DSGN
$12.62 +0.26 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

Design Therapeutics (DSGN) Common Equity (2020 - 2026)

Updated

Design Therapeutics (DSGN) posted Common Equity of $201.86 million for Q2 2026, down 5.2% from $213.04 million a year earlier and down 7.4% from the prior quarter.

Analysis

Design Therapeutics (DSGN) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Design Therapeutics' Common Equity came in at $212.5 million, down 12.2% from FY2024.

  • Annual Common Equity has declined for four consecutive years.
  • In prior years, Design Therapeutics' Common Equity was $242.1 million in FY2024 (-12.8%), $277.69 million in FY2023 (-15.2%), $327.31 million in FY2022 (-14.3%) and $382.13 million in FY2021.
  • Quarterly Common Equity has run from a low of $199.72 million in Q3 2025 to a high of $391.56 million in Q3 2021 over five years.
  • On a year-over-year basis, Common Equity has declined in each of the last 18 quarters, with an average decline of 12.6% over the last eight quarters.
  • The year-over-year decline in Common Equity has ranged between 4.3% (Q1 2026) and 20.9% (Q3 2025) over the last five years.
  • According to Business Quant data, Common Equity for the three prior quarters was $218.05 million (Q1 2026), $212.5 million (Q4 2025) and $199.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Design Therapeutics 773.49 Mn -82.54 Mn - 201.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 201.86 Mn
Mar 31, 2026 218.05 Mn
Dec 31, 2025 212.50 Mn
Sep 30, 2025 199.72 Mn
Jun 30, 2025 213.04 Mn
Mar 31, 2025 227.92 Mn
Dec 31, 2024 242.10 Mn
Sep 30, 2024 252.45 Mn
Jun 30, 2024 261.24 Mn
Mar 31, 2024 269.56 Mn
Dec 31, 2023 277.69 Mn
Sep 30, 2023 284.96 Mn
Jun 30, 2023 296.80 Mn
Mar 31, 2023 312.82 Mn
Dec 31, 2022 327.31 Mn
Sep 30, 2022 340.94 Mn
Jun 30, 2022 357.16 Mn
Mar 31, 2022 370.31 Mn
Dec 31, 2021 382.13 Mn
Sep 30, 2021 391.56 Mn
API Access

Design Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=DSGN&period=max&api_key=YOUR_API_KEY